Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis - PubMed (original) (raw)

Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis

M K Sharief et al. J Neurol Neurosurg Psychiatry. 1993 Feb.

Abstract

Concentrations of interleukin-2 (IL-2) and soluble IL-2 receptor (sIL-2R) in serum and CSF samples were measured in 63 patients with multiple sclerosis (MS) to evaluate their usefulness as markers of disease activity. CSF concentrations of IL-2 and sIL-2R were significantly higher in MS relapse compared with MS patients in remission or with control subjects. These concentrations correlated with the clinical score by which disease severity was assessed, with the number of relapses per year, and with the total disease duration. Furthermore, there was evidence of intrathecal release of IL-2 and sIL-2R in clinically active MS. The results extend the notion that an activated cellular immune state parallels the evolution of the pathological process in MS and suggest that measurement of IL-2 and sIL-2R concentrations may provide an objective marker of disease activity in patients with MS.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurology. 1986 Oct;36(10):1392-5 - PubMed
    1. J Neurol. 1993 Jan;240(1):46-50 - PubMed
    1. Ann Neurol. 1987 Nov;22(5):658-61 - PubMed
    1. Clin Exp Immunol. 1987 Dec;70(3):570-7 - PubMed
    1. Science. 1988 May 27;240(4856):1169-76 - PubMed

MeSH terms

Substances

LinkOut - more resources